Optimized synthesis of anti-COVID-19 drugs aided by retrosynthesis software-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimized synthesis of anti-COVID-19 drugs aided by retrosynthesis software

Published:2023 Issue:7 Volume:14 Page:1254-1259
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Qi Wentao¹^ORCID,Zhai Dong¹^ORCID,Song Danna¹,Liu Chengcheng¹^ORCID,Yang Junxia¹,Sun Lei¹^ORCID,Li Youyong²^ORCID,Li Xingwei¹^ORCID,Deng Weiqiao¹^ORCID

Affiliation:

1. Institute of Molecular Sciences and Engineering, Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao 266237, P. R. China

2. Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou 215123, P. R. China

Abstract

We applied AI-aided retrosynthesis strategy optimized synthesis routes for several anti-COVID-19 drugs.

Funder

National Key Research and Development Program of China

Shandong University

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/MD/D2MD00444E

Reference42 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Rapid repurposing of drugs for COVID-19

3. COVID-19: Drug Targets and Potential Treatments

4. Molecular Insights into Small‐Molecule Drug Discovery for SARS‐CoV‐2

5. Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP